Evaxion A/S (EVAX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.83, +1.07% vs the prior close of $2.80.
- Volume 74.13K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EVAX rises 1.1% to $2.83. Closed at $2.83, +1.07% vs the prior close of $2.80. Day range $2.79β$2.92, opened at $2.85.
EVAX daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β EVAX rises 1.1% to $2.83
- Closed at $2.83, +1.07% vs the prior close of $2.80. Day range $2.79β$2.92, opened at $2.85.
- Volume was 74.13K shares, 0.3x its 50-day average of 257.44K β lighter than usual.
- Price is -9.8% vs its 50-day average ($3.14) and -21.0% vs its 200-day average ($3.58).
- 52-week range $2.72β$11.51; today's close sits at 1% of that range, 75.4% below the 52-week high.
Oct 15, 2026 β EVAX ends flat (+0.0%) to $2.80
- Closed at $2.80, +0.00% vs the prior close of $2.80. Day range $2.79β$2.90, opened at $2.80.
- Volume was 35.10K shares, 0.1x its 50-day average of 256.93K β lighter than usual.
- Price is -10.9% vs its 50-day average ($3.14) and -22.1% vs its 200-day average ($3.59).
- 52-week range $2.72β$12.15; today's close sits at 1% of that range, 77.0% below the 52-week high.
Oct 14, 2026 β EVAX rises 1.4% to $2.80
- Closed at $2.80, +1.45% vs the prior close of $2.76. Day range $2.75β$2.83, opened at $2.76.
- Volume was 50.40K shares, 0.2x its 50-day average of 256.14K β lighter than usual.
- Price is -11.0% vs its 50-day average ($3.14) and -22.3% vs its 200-day average ($3.60).
- 52-week range $2.72β$12.15; today's close sits at 1% of that range, 77.0% below the 52-week high.
Oct 13, 2026 β EVAX slides 8.0% to $2.76, a 52-week low
- Closed at $2.76, -8.00% vs the prior close of $3.00. Day range $2.72β$2.99, opened at $2.98.
- Volume was 133.80K shares, 0.5x its 50-day average of 253.62K β lighter than usual.
- Price is -12.3% vs its 50-day average ($3.15) and -23.7% vs its 200-day average ($3.62).
- 52-week range $2.72β$12.15; today's close sits at 0% of that range, 77.3% below the 52-week high.
Oct 12, 2026 β EVAX dips 2.3% to $3.00, a 1-month low
- Closed at $3.00, -2.28% vs the prior close of $3.07. Day range $2.99β$3.23, opened at $3.07.
- Volume was 60.80K shares, 0.2x its 50-day average of 252.71K β lighter than usual.
- Price is -4.7% vs its 50-day average ($3.15) and -17.3% vs its 200-day average ($3.63).
- 52-week range $2.77β$12.15; today's close sits at 2% of that range, 75.3% below the 52-week high.
Oct 9, 2026 β EVAX rises 0.7% to $3.07
- Closed at $3.07, +0.66% vs the prior close of $3.05. Day range $3.02β$3.13, opened at $3.03.
- Volume was 27.90K shares, 0.1x its 50-day average of 252.32K β lighter than usual.
- Price is -2.4% vs its 50-day average ($3.14) and -15.5% vs its 200-day average ($3.63).
- 52-week range $2.77β$12.15; today's close sits at 3% of that range, 74.7% below the 52-week high.
Oct 8, 2026 β EVAX slides 3.5% to $3.05
- Closed at $3.05, -3.48% vs the prior close of $3.16. Day range $3.02β$3.23, opened at $3.18.
- Volume was 64.00K shares, 0.3x its 50-day average of 251.30K β lighter than usual.
- Price is -2.9% vs its 50-day average ($3.14) and -16.3% vs its 200-day average ($3.65).
- 52-week range $2.77β$12.15; today's close sits at 3% of that range, 74.9% below the 52-week high.
Oct 7, 2026 β EVAX ends flat (+0.0%) to $3.16
- Closed at $3.16, +0.00% vs the prior close of $3.16. Day range $3.11β$3.25, opened at $3.16.
- Volume was 21.70K shares, 0.1x its 50-day average of 251.29K β lighter than usual.
- Price is +0.8% vs its 50-day average ($3.14) and -13.5% vs its 200-day average ($3.65).
- 52-week range $2.77β$12.15; today's close sits at 4% of that range, 74.0% below the 52-week high.
Oct 6, 2026 β EVAX rises 0.3% to $3.16
- Closed at $3.16, +0.32% vs the prior close of $3.15. Day range $3.12β$3.25, opened at $3.24.
- Volume was 35.90K shares, 0.1x its 50-day average of 250.82K β lighter than usual.
- Price is +1.0% vs its 50-day average ($3.13) and -13.8% vs its 200-day average ($3.67).
- 52-week range $2.77β$12.15; today's close sits at 4% of that range, 74.0% below the 52-week high.
Oct 5, 2026 β EVAX dips 1.6% to $3.15
- Closed at $3.15, -1.56% vs the prior close of $3.20. Day range $3.14β$3.24, opened at $3.20.
- Volume was 38.20K shares, 0.2x its 50-day average of 250.12K β lighter than usual.
- Price is +0.9% vs its 50-day average ($3.12) and -14.4% vs its 200-day average ($3.68).
- 52-week range $2.77β$12.15; today's close sits at 4% of that range, 74.1% below the 52-week high.
Oct 2, 2026 β EVAX rises 0.6% to $3.20
- Closed at $3.20, +0.63% vs the prior close of $3.18. Day range $3.16β$3.28, opened at $3.23.
- Volume was 33.90K shares, 0.1x its 50-day average of 249.65K β lighter than usual.
- Price is +2.6% vs its 50-day average ($3.12) and -13.4% vs its 200-day average ($3.69).
- 52-week range $2.77β$12.15; today's close sits at 5% of that range, 73.7% below the 52-week high.
- SEC filings that day: 6-K.
EVAX latest news & SEC filings
Every SEC filing by or about EVAX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 14, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 4, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 20, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 20, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 17, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 14, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 17, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 1, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade EVAX
- How much it moves: over the last 20 sessions the average daily move was 1.69% (largest 8.0%).
- Liquidity: about 45.60K shares (β$129.04K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.83 vs a range of $2.72β$11.51 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:5 on Jan 14, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 2, 2026; 6-K Sep 14, 2026; 6-K Sep 4, 2026.
- Listing: Nasdaq Β· industry: Biological Products, (No Diagnostic Substances).
EVAX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.85 | 2.92 | 2.79 | 2.83 | 74.13K |
| Oct 15, 2026 | 2.80 | 2.90 | 2.79 | 2.80 | 35.10K |
| Oct 14, 2026 | 2.76 | 2.83 | 2.75 | 2.80 | 50.40K |
| Oct 13, 2026 | 2.98 | 2.99 | 2.72 | 2.76 | 133.80K |
| Oct 12, 2026 | 3.07 | 3.23 | 2.99 | 3.00 | 60.80K |
| Oct 9, 2026 | 3.03 | 3.13 | 3.02 | 3.07 | 27.90K |
| Oct 8, 2026 | 3.18 | 3.23 | 3.02 | 3.05 | 64.00K |
| Oct 7, 2026 | 3.16 | 3.25 | 3.11 | 3.16 | 21.70K |
| Oct 6, 2026 | 3.24 | 3.25 | 3.12 | 3.16 | 35.90K |
| Oct 5, 2026 | 3.20 | 3.24 | 3.14 | 3.15 | 38.20K |
| Oct 2, 2026 | 3.23 | 3.28 | 3.16 | 3.20 | 33.90K |
| Oct 1, 2026 | 3.25 | 3.29 | 3.13 | 3.18 | 38.10K |
| Sep 30, 2026 | 3.35 | 3.35 | 3.24 | 3.28 | 18.00K |
| Sep 29, 2026 | 3.20 | 3.31 | 3.20 | 3.27 | 38.10K |
| Sep 28, 2026 | 3.34 | 3.35 | 3.19 | 3.24 | 55.70K |
| Sep 25, 2026 | 3.30 | 3.35 | 3.24 | 3.34 | 45.00K |
| Sep 24, 2026 | 3.30 | 3.35 | 3.25 | 3.26 | 36.90K |
| Sep 23, 2026 | 3.33 | 3.35 | 3.24 | 3.28 | 35.20K |
| Sep 22, 2026 | 3.18 | 3.31 | 3.18 | 3.27 | 32.30K |
| Sep 21, 2026 | 3.24 | 3.25 | 3.17 | 3.21 | 36.80K |
About Evaxion A/S
Evaxion A/S (EVAX) is listed on the Nasdaq and classified by the SEC under βBiological Products, (No Diagnostic Substances)β. Its business address is in HOERSHOLM. State of incorporation: Denmark. Fiscal year ends December 31. SEC CIK 1828253.
EVAX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jens Bitsch-Norhave | Director | Apr 24, 2026 |
| Lars Holtug | Director | Mar 18, 2026 |
| Roberto Prego | Director | Mar 27, 2026 |
| Marianne Soegaard | Director | Apr 2, 2026 |
| Lars Aage Staal Wegner | Director | Apr 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| A/S Evaxion | Chief Executive Officer | Mar 18, 2026 |
| Andreas Holm Mattsson | CAIO Chief AI Officer | Apr 10, 2026 |
| Birgitte Rono | Chief Scientific Officer | Mar 27, 2026 |
| Thomas Frederik Schmidt | Chief Financial Officer | Mar 27, 2026 |
| Helen Katrina Tayton-Martin | Chief Executive Officer | Mar 31, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
EVAX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
EVAX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EVAX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.